CTAG2 Polyclonal Antibody, PE-Cy5 Conjugated
Product Specifications
Background
Testis and very low level in placenta and in some uterus samples. Observed in 25-50% of tumor samples of melanomas, non-small-cell lung carcinomas, bladder, prostate and head and neck cancers.
Synonyms
CT2; ESO2; CAMEL; CT6.2; CT6.2a; CT6.2b; LAGE-1; LAGE2B; Cancer/testis antigen 2; Autoimmunogenic cancer/testis antigen NY-ESO-2; Cancer/testis antigen 6.2; L antigen family member 1; CTAG2; LAGE1
Gene ID
30848
Swiss Prot
O75638
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human
Immunogen
121-210/210
Target
CTAG2
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from human CTAG2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
30848
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H1827-65 200 µg
HDAC5 (HD5, FLJ90614, KIAA0600, NY-CO-9, Histone Deacetylase 5) discontinued
Ask
View Details